Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Pace Megan E
SVP, Corp. Communications at Vertex Pharmaceuticals. Filing since 8 Jul 2013.
CIK 0001554979
Company
Date
Role
Action
Shares
Amount
Of holding
VRTX
Vertex Pharmaceuticals
17 Nov 2014
SVP, Corp. Communications
Sold, plan not stated
33
$3.69K
0.1%
VRTX
Vertex Pharmaceuticals
30 Sep 2014
SVP, Corp. Communications
Sold, plan not stated
56,486
$6.36M
70.8%
VRTX
Vertex Pharmaceuticals
24 Jun 2014
SVP, Corp. Communications
Sold, plan not stated
12,734
$1.25M
35.3%
VRTX
Vertex Pharmaceuticals
15 May 2014
SVP, Corp. Communications
Sold, plan not stated
369
$24.23K
1.6%
VRTX
Vertex Pharmaceuticals
2 May 2014
SVP, Corp. Communications
Sold, plan not stated
1,000
$67.62K
4.1%
VRTX
Vertex Pharmaceuticals
21 Jan 2014
SVP, Corp. Communications
Sold, plan not stated
1,250
$106.25K
11.0%
VRTX
Vertex Pharmaceuticals
6 Jan 2014
SVP, Corp. Communications
Sold, plan not stated
838
$62.85K
6.9%
VRTX
Vertex Pharmaceuticals
12 Dec 2013
SVP, Corp. Communications
Sold, plan not stated
5,083
$332.83K
29.4%
VRTX
Vertex Pharmaceuticals
15 Nov 2013
SVP, Corp. Communications
Sold, plan not stated
93
$5.67K
0.5%
VRTX
Vertex Pharmaceuticals
12 Jul 2013
SVP, Corp. Communications
Sold, plan not stated
5,678
$487.63K
24.7%
VRTX
Vertex Pharmaceuticals
11 Jul 2013
SVP, Corp. Communications
Sold, plan not stated
5,000
$420.00K
21.8%
VRTX
Vertex Pharmaceuticals
8 Jul 2013
SVP, Corp. Communications
Sold, plan not stated
28,703
$2.32M
61.5%
12 decisions on file.
